TTrialPathMatch Me to Trials
← Back to trials
RecruitingPeripheral Neuropathy With Type 2 Diabetes

A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy

Eligible age

45–85 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Diabetic peripheral neuropathy is one of the most common and costly microvascular complications of diabetes impacting more than 50% of patients and costing more than 10.1 billion dollars annually. Intraneural Facilitation Therapy (INF® Therapy) is a non-invasive technique that has shown to improve balance and pain in patients with Type 2 Diabetic Peripheral Neuropathy (T2DPN); however, the underlying physiological mechanisms need further understanding. The purpose of this study is to investigate the physiological mechanisms behind two approaches to treating T2DPN, INF® Therapy and standard physical therapy. Eligible subjects presenting with diabetic neuropathy symptoms will be recruited and referred to the Loma Linda University Health's Neuropathic Therapy Center. Forty patients will be evenly randomized into two groups: an INF® Therapy Treatment group and standard physical therapy treatment group. Subjects will participate in 11 study visits over a period of 6 weeks. Non-invasive assessments will measure neuropathy pain, heart rate variability, neuropathy severity, blood oxygen levels, and blood flow under the skin. Lab draws will measure inflammation levels in the blood and how well blood sugar levels have been maintained over a period of about 3 months. Descriptive statistics and repeated measures ANOVA will be used to analyze data and answer the research questions. The findings of this study will provide a better understanding of how INF® Therapy and standard physical therapy work, subsequently improving non-invasive treatment methods for T2DPN patients.

Sponsor: Loma Linda University

You may qualify if…

  • Between the ages of 45 and 85
  • Moderate to severe type II diabetic neuropathy with one or more symptoms including: numbness, tingling, burning, sharp pain, and/or increased sensitivity.
  • Diagnosis confirmed by a physician.
  • Cellphone access with Android 5.0 and up or iOS 14.0 or later.

You may not qualify if…

  • Subjects with a medical condition predisposing them to medical decline during the next 6 months will be excluded from the study. Examples include:
  • Chemotherapy
  • Radiation
  • Lower extremity amputations
  • Open wounds
  • Documented active drug and or alcohol misuse
  • Chronic liver disease
  • Active inflammations

Where it's recruiting

California

Loma Linda

Source: ClinicalTrials.gov · NCT05577390 · last updated 2025-11-19

A Physiologic Comparison of Two Approaches to Treating Peripheral Neur · TrialPath